STING1 and pancreatic ductal adenocarcinoma: However, in a preclinical study of pancreatic ductal adenocarcinoma (PDAC), it was shown that cell lines defective in the STING pathway had relatively low susceptibility to being C-REV (a type of HSV) (111).